Home / 2021 / May / 15

Daily Archives: May 15, 2021

Eostre Berhad, Toga Limited’s Majority-Owned Malaysian Subsidiary, Enters Into an Exclusive Distribution Agreement With Biosurges Co., Ltd.

PETALING JAYA, Malaysia, May 14, 2021 (GLOBE NEWSWIRE) — Eostre Berhad, Toga Limited’s (OTC: TOGL) majority-owned subsidiary, entered into an exclusive distribution agreement with Taiwan’s Biosurges Co., Ltd. on March 15, 2021. This Agreement appoints Eostre as the exclusive distributor of its Dammarane dietary supplements in Malaysia and Singapore.

Eostre will now be tasked with developing the largest possible market in Malaysia and Singapore for the product – a botanical beverage of mixed berries and ginseng extract.

“We’re happy to establish this collaboration between Biosurges and Eostre to become the official, exclusive distributor for Malaysia and Singapore. Although the pandemic has been a challenging time for many businesses, we have placed an emphasis on sustainable business growth and diversification of revenue streams.

For Eostre, the introduction of new product lines will help generate results that are profitable. As the exclusive distributor of Biosurges, Eostre believes this will provide momentum for the growth of Eostre’s product portfolio and customer base in the two countries,” said Eostre Berhad General Manager, Ms. Low Kah Fong.

“We’re quite pleased to begin this relationship with Biosurges, and we anticipate both companies will jointly expand the awareness and demand for the Dammarane products in the nutritional and dietary market segments in Malaysia and Singapore.

This collaboration will certainly pave the way for continued strong growth in dietary supplement and nutrition space, in line with Eostre’s vision of becoming an international brand with world-leading healthcare products, and mission of promoting healthy living with innovative technology,” said Eostre Chief Executive Officer, Mr. Tan Chiau Wei.


Alexander D. Henderson
TOGA LIMITED, 515 S. Flower Street, 18th Floor, Los Angeles, CA 90071
(949) 333-1603

Certain statements in this press release are forward-looking as defined in the Private Securities Litigation Reform Act of 1995. Any statements contained herein that are not statements of historical fact (including, but not limited to, statements to the effect that Toga Limited or its management (the “Company”) “anticipates,” “plans,” “estimates,” “expects,” or “believes,” or the negative of these terms and other similar expressions) should be considered forward-looking statements, including, without limitation, statements regarding the Company’s guidance, outlook, growth, opportunities and long-term strategy. These statements involve certain risks and uncertainties that may cause actual results to differ materially from expectations as of the date of this release. These risks and uncertainties include, without limitation, risks associated with the impact of the COVID-19 pandemic; the Company’s ability to execute on its long-term strategy; the Company’s ability to successfully compete in its intensely competitive industry; the Company’s ability to manage its growth; the Company’s ability to maintain or improve its operating margins; the Company’s ability to identify and react to trends in consumer preferences; product supply disruptions; general economic conditions; accounting standard changes; and other factors as set forth from time to time in the Company’s Securities and Exchange Commission filings, including, without limitation, the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company intends these forward-looking statements to speak only as of the time of this Press Release and does not undertake to update or revise them as more information becomes available, except as required by law.

Heart Study: Low- and Regular-Dose Aspirin Prove Safe, Effective

An unusual study that had thousands of heart disease patients enroll themselves and track their health online as they took low- or regular-strength aspirin concluded that both doses seem equally safe and effective for preventing additional heart problems and strokes.

But there’s a big caveat: People had such a strong preference for the lower dose that it’s unclear if the results can establish that the treatments are truly equivalent, some independent experts said. Half who were told to take the higher dose took the lower one instead or quit using aspirin altogether.

“Patients basically decided for themselves” what they wanted to take because they bought the aspirin on their own, said Dr. Salim Virani, a cardiologist at Baylor College of Medicine in Houston, who had no role in the study.

Still, the results show there’s little reason to take the higher dose, 325 milligrams, which many doctors assumed would work better than 81-milligram “baby aspirin,” he said.

Results were published Saturday by The New England Journal of Medicine and discussed at an American College of Cardiology conference.

Who benefits from it

Aspirin helps prevent blood clots, but it’s not recommended for healthy people who have not yet developed heart disease because it carries a risk of bleeding. Its benefits are clear, though, for folks who have had a heart attack, bypass surgery or clogged arteries requiring a stent.

But the best dose isn’t known, and the study aimed to compare them in a real-world setting. The study was funded by the Patient-Centered Outcomes Research Institute, created under the 2010 Patient Protection and Affordable Care Act, commonly called Obamacare, to help patients make informed decisions about health care.

About 15,000 people received invitations to join through the mail, email or a phone call and enrolled on a website where they returned every three to six months for follow-up. A network of participating health centers supplied medical information on participants from their electronic records and insurance claims.

The participants were randomly assigned to take low- or regular-dose aspirin, which they bought over the counter. Nearly all were taking aspirin before the study began and 85% were already on a low dose, so “it was an uphill task right from the get-go” to persuade people to use the dose they were told, Virani said.

After roughly two years, about 7% of each group had died or been hospitalized for a heart attack or a stroke. Safety results also were similar — less than 1% had major bleeding requiring hospitalization and a transfusion.

Many switched

Nearly 41% of those assigned to take the higher dose switched at some point to the lower one, and that high rate “could have obscured a true difference” in safety or effectiveness, Colin Baigent, a medical scientist at the University of Oxford in the United Kingdom, wrote in a commentary in the medical journal.

One study leader, Dr. Schuyler Jones of Duke University, said the study still provides valuable guidance. If patients are taking low-dose aspirin now, “staying on that dose instead of switching is the right choice,” he said. People doing well on 325 milligrams now may want to continue on that and should talk with their doctors if they have any concerns.

For new patients, “in general, we’re going to recommend starting the low dose,” Jones said.

Virani said people must remember that aspirin is a medicine and that even though it’s sold over the counter, patients shouldn’t make decisions on its use by themselves.

“Don’t change the dose or stop without talking to someone,” he warned. “This is important, especially for a therapy like aspirin.”

Source: Voice of America

CDC Issues Mask, Distancing Guidance for Students

When schools in the United States open this fall, students from kindergarten through 12th grade should wear masks, the U.S. Centers for Disease Control and Prevention said Saturday, as it refines its guidance against the coronavirus.

Because not every student will not be fully vaccinated, the CDC says masks should be worn while riding buses and while inside schools. It also urges students and teachers to remain 2 meters of social distancing.

The Pfizer-BioNTech vaccine was approved earlier this month for children, ages 12 and older.

Just days ago, on Thursday, the agency announced that fully vaccinated people did not need to wear a mask, for the most part.

Surge sweeps rural India

India reported its smallest daily gain in COVID-19 cases in nearly three weeks Saturday, continuing a trend that began last week as the government warns of an overwhelming surge sweeping across rural areas.

India’s health ministry reported 326,098 new COVID-19 cases in the previous 24-hour period and 3,890 COVID deaths.

Federal health officials in India said at a briefing the overall rate of infections fell to 19.8% this week from 21.9% the week before.

But the virus continues to spread aggressively to rural areas, where two-thirds of the country’s 1.4 billion people live.

Amid news reports of sick people in rural areas being rushed to towns and cities for treatment, Prime Minister Narendra Modi ordered his government to mobilize all resources to distribute oxygen supplies and other medical aid to hard-hit rural areas.

Virus flares in Taiwan

In Taiwan, Taipei and New Taipei City are on a Level 3 alert, one level short of a full lockdown, following a surge of 180 COVID-19 cases. The new infections bring Taiwan’s total cases to just under 1,500. The Level 3 alert requires mandatory mask wearing outdoors and restricts the size of social gatherings.

Taiwan has been hailed as a pandemic success story because it had not had any new cases in months. So, when the number of new cases took a triple digit jump Saturday, mostly in the two cities, officials acted.

“The epidemic is gaining intensity,” Health Minister Chen Shih-chung told reporters at a briefing Saturday.

Lockdown in Caribbean

A surge in COVID-19 cases and deaths is prompting a state of emergency and curfew beginning early Sunday in Trinidad and Tobago. According to Johns Hopkins Coronavirus Resource Center, the twin island state has seen 2,659 new cases of COVID-19 and 69 new deaths in the past week. Both are records.

Health officials say the variant first found in Brazil, which is highly transmissible, is partly to blame. More than 61,000 shots have gone into arms in Trinidad and Tobago, but only 1,179 people are fully vaccinated.

Only the U.S. has recorded more total COVID-19 cases than India. According to Johns Hopkins, the U.S. has more than 32.9 million infections, while India has nearly 24.4 million. Public health officials, however, believe that India has undercounted its cases. Johns Hopkins reports the global count of COVID-19 cases is more than 162,000,000.

Source: Voice of America